NCT01367353

Brief Summary

Specific aims: Identification and characterization of cancer stem cell-like population (cancer stem cells or cancer initiating cells) from primary tumor tissue, primary ascites and peripheral blood of ovarian cancer patients and genetically engineered mouse ovarian cancer cell lines. Objectives: In the future, individualized therapy must incorporate analysis of the cancer stem cells or cancer initiating cells of ovarian cancer cells when designing therapeutic strategies for ovarian cancer patients. Aims of this project:

  1. 1.Isolation and identification of cancer stem cell-like population (cancer stem cells or cancer initiating cells) from primary tumor tissue, primary ascites and peripheral blood of ovarian cancer patients
  2. 2.In vivo tumorigenicity assay will be performed to measure tumor formation from these cancer stem cell-like population when equal numbers were injected into the dorsal fat pad of nude mice.
  3. 3.To establish a standard protocol of stem cell-like population maintenance
  4. 4.Screening of potential specific biomarkers involved in these ovarian cancer stem cell-like population.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P50-P75 for not_applicable ovarian-cancer

Timeline
Completed

Started Jan 2010

Typical duration for not_applicable ovarian-cancer

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

December 10, 2010

Completed
6 months until next milestone

First Posted

Study publicly available on registry

June 7, 2011

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
Last Updated

June 7, 2011

Status Verified

May 1, 2011

Enrollment Period

1.9 years

First QC Date

December 10, 2010

Last Update Submit

June 6, 2011

Conditions

Outcome Measures

Primary Outcomes (1)

  • overall survival

    From disease diagnosis to death (Generally 2~5 years)

Study Arms (1)

ovarian cancer

EXPERIMENTAL
Procedure: surgery or debulking surgery

Interventions

surgery or debulking surgery

ovarian cancer

Eligibility Criteria

Age15 Years - 80 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with ovarian carcinoma who undergo hysterectomy, bilateral oophorectomy and tubal resection, omentectomy, and appendectomy will be enrolled and the clinical data will be obtained from our hospital.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, Taiwan

RECRUITING

MeSH Terms

Conditions

Ovarian Neoplasms

Interventions

Surgical Procedures, Operative

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Neoplasms, FemaleUrogenital NeoplasmsGenital DiseasesEndocrine System DiseasesGonadal Disorders

Study Officials

  • Wen-Fang Cheng, Professor

    National Taiwan University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Wen-Fang Cheng, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 10, 2010

First Posted

June 7, 2011

Study Start

January 1, 2010

Primary Completion

December 1, 2011

Study Completion

December 1, 2013

Last Updated

June 7, 2011

Record last verified: 2011-05

Locations